C. Kennedy

A. Accarino, M. Jimenez, P. Vergara, 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Evidence for functional sodium and calcium ion channels in the membrane of cultured cardiomyocytes of the adult rat.

G. Mealing, S. L. Jacobson, C. Kennedy, 1983, Canadian journal of physiology and pharmacology.

P2X7 subunit-like immunoreactivity in the nucleus of visceral smooth muscle cells of the guinea pig

J. Menzies, C. Kennedy, A. Paul, 2003, Autonomic Neuroscience.

Characteristics of Ligand-Gated Ion Channel P2 Nucleotide Receptors

S. Hickman, S. Silverstein, C. Kennedy, 1998 .

Morrow, Gael B. and Nicholas, Robert A. and Kennedy, Charles (2014) UTP is not a biased agonist at human P2Y11 receptors. Purinergic

R. Nicholas, C. Kennedy, G. Morrow, 2017 .

[Met5]enkephalin acts via δ‐opioid receptors to inhibit pelvic nerve‐evoked contractions of cat distal colon

C. Kennedy, J. Krier, Jacob Krier, 1987, British journal of pharmacology.

δ‐Opioid receptors mediate inhibition of fast excitatory postsynaptic potentials in cat parasympathetic colonic ganglia

C. Kennedy, J. Krier, 1987, British journal of pharmacology.

P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery.

G. Burnstock, C. Kennedy, D. Delbro, 1985, European journal of pharmacology.

Regional variation in P2 receptor expression in the rat pulmonary arterial circulation

A. Gurney, C. Kennedy, K. Chootip, 2002, British journal of pharmacology.

Indirect evidence that purinergic modulation of perivascular adrenergic neurotransmission in the portal vein is a physiological process

G. Burnstock, C. Kennedy, R. Crowe, 1984, British journal of pharmacology.

Adenosine and ATP: progress in their receptors' structures and functions.

B. Khakh, C. Kennedy, 1998, Trends in pharmacological sciences.

Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists

A. Gurney, C. Kennedy, Callum Mitchell, 2022, Purinergic Signalling.

UDP..beta..S

C. Kennedy, 2008 .

Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery

A. Gurney, C. Kennedy, K. Chootip, 2005, Respiratory research.

Behavioral / Systems / Cognitive Identification of Atropine-and P 2 X 1 Receptor Antagonist-Resistant , Neurogenic Contractions of the Urinary Bladder

C. Kennedy, T. Westfall, P. N. Tasker, 2017 .

Identification of Atropine- and P2X1 Receptor Antagonist-Resistant, Neurogenic Contractions of the Urinary Bladder

C. Kennedy, T. Westfall, P. N. Tasker, 2007, The Journal of Neuroscience.

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

Stephen P. H. Alexander, Leigh A. Stoddart, Kalyan C. Tirupula, 2021, British journal of pharmacology.

Chapter 9 – ATP as a Cotransmitter with Noradrenaline in Sympathetic Perivascular Nerves

C. Kennedy, 1993 .

ATP produces vasodilation via P1 purinoceptors and vasoconstriction via P2 purinoceptors in the isolated rabbit central ear artery.

G. Burnstock, C. Kennedy, 1985, Blood vessels.

International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy

Eric A. Barnard, Geoffrey Burnstock, Kenneth A. Jacobson, 2006, Pharmacological Reviews.

The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor.

G. Burnstock, K. Jacobson, E. Barnard, 2005, Trends in pharmacological sciences.

Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells

G. Henderson, C. Kennedy, 1992, Neuroscience.

Is there a basis for distinguishing two types of P2-purinoceptor?

G Burnstock, G. Burnstock, C. Kennedy, 1985, General pharmacology.

Investigation of the actions of PPADS, a novel P2X‐purinoceptor antagonist, in the guinea‐pig isolated vas deferens

H. Bäumert, C. Kennedy, E. Mutschler, 1994, British journal of pharmacology.

ATP causes postjunctional potentiation of noradrenergic contractions in the portal vein of guinea‐pig and rat *

G. Burnstock, C. Kennedy, Geoffrey Burnstock, 1986, The Journal of pharmacy and pharmacology.

Purinergic cotransmission: sympathetic nerves

C. Kennedy, P. Sneddon, G. J. McLaren, 1996 .

P1- and P2-purinoceptor subtypes--an update.

C. Kennedy, 1990, Archives internationales de pharmacodynamie et de therapie.

The interaction of diadenosine polyphosphates with P2X‐receptors in the guinea‐pig isolated vas deferens

C. Kennedy, P. Sneddon, J. Bowes, 1997, British journal of pharmacology.

Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.

G. Burnstock, K. Jacobson, E. Barnard, 2003, Trends in pharmacological sciences.

International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.

B S Khakh, G Burnstock, C Kennedy, 2001, Pharmacological reviews.

P2X Receptors: Targets for Novel Analgesics?

C. Kennedy, 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

Inhibition of potassium currents by the sigma receptor ligand (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine in sympathetic neurons of the mouse isolated hypogastric ganglion

G. Henderson, C. Kennedy, Graeme Henderson, 1990, Neuroscience.

The sigma [corrected] ligand rimcazole antagonises (+)SKF 10,047, but not (+)3-PPP, in the mouse isolated vas deferens.

G. Henderson, C. Kennedy, G. Jarvis, 1990, European journal of pharmacology.

Pharmacological properties of P2X3‐receptors present in neurones of the rat dorsal root ganglia

E. Rowan, C. Kennedy, E G Rowan, 1998, British journal of pharmacology.

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels

Adam J Pawson, Stephen P. H. Alexander, L. Kaczmarek, 2021, British journal of pharmacology.

ATP as a cotransmitter in the autonomic nervous system

C. Kennedy, 2015, Autonomic Neuroscience.

Atp as an Excitatory Cotransmitter in the Autonomic Nervous System

C. Kennedy, 2022 .

How should P2X purinoceptors be classified pharmacologically?

P. Leff, C. Kennedy, P Leff, 1995, Trends in pharmacological sciences.

Characterization of P2‐purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses

R. Evans, R J Evans, C. Kennedy, 1994, British journal of pharmacology.

Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein.

G. Burnstock, C. Kennedy, 1985, European journal of pharmacology.

P2X receptors in health and disease.

G. Burnstock, C. Kennedy, 2011, Advances in pharmacology.

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30

F. Di Virgilio, K. Jacobson, C. Müller, 2020, British journal of pharmacology.

Differential coupling of the human P2Y11 receptor to phospholipase C and adenylyl cyclase

R. Nicholas, C. Kennedy, T K Harden, 2001, British journal of pharmacology.

The Role of Purines in the Peripheral Nervous System

C. Kennedy, 2001 .

Comparison of the actions of ATP and UTP and P(2X1) receptors in smooth muscle of the rat tail artery.

C. Kennedy, P. Sneddon, G. J. McLaren, 1998, European journal of pharmacology.

That was then, this is now: the development of our knowledge and understanding of P2 receptor subtypes

C. Kennedy, 2021, Purinergic Signalling.

The P2Y/P2X divide: how it began.

C. Kennedy, 2021, Biochemical pharmacology.

The discovery and development of P2 receptor subtypes.

C. Kennedy, 2000, Journal of the autonomic nervous system.

Identification of Contractile P2Y1, P2Y6, and P2Y12 Receptors in Rat Intrapulmonary Artery Using Selective Ligands

A. Gurney, C. Kennedy, Callum Mitchell, 2012, Journal of Pharmacology and Experimental Therapeutics.

Identification of Contractile P 2 Y 1 , P 2 Y 6 , and P 2 Y 12 Receptors in Rat Intrapulmonary Artery Using Selective Ligands

A. Gurney, C. Kennedy, Callum Mitchell, 2012 .

Characterisation of P2X receptors expressed in rat pulmonary arteries.

C. Kennedy, A. Paul, A. Tengah, 2010, European journal of pharmacology.

P2X and P2Y nucleotide receptors as targets in cardiovascular disease.

C. Kennedy, Callum Mitchell, K. Chootip, 2013, Future medicinal chemistry.

Pharmacology of P2X receptors

C. Kennedy, Nawazish-i-Husain Syed, 2012 .

Modulation of purinergic neurotransmission by ecto-ATPase

C. Kennedy, P. Sneddon, T. Westfall, 1996 .

ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.

R. Nicholas, C. Kennedy, C. L. Herold, 2000, Molecular pharmacology.

The effects of suramin on purinergic and noradrenergic neurotransmission in the rat isolated tail artery.

C. Kennedy, P. Sneddon, G. J. McLaren, 1995, European journal of pharmacology.

An examination of the putative σ‐receptor in the mouse isolated vas deferens

G. Henderson, C. Kennedy, 1989 .

Metabolism of histamine in secreting intact and isolated canine stomach

Jerry, J., É., 2003 .

Highlights in Purinergic Signalling

C. Kennedy, 2009, Purinergic Signalling.

P2X receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Francesco Di Virgilio, Richard J. Evans, Simonetta Falzoni, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

ATP as a co-transmitter with noradrenaline in sympathetic nerves--function and fate.

C. Kennedy, P. Sneddon, T. Westfall, 2007, Ciba Foundation symposium.

Reactive Blue 2 (Baselene Blue 3G)

C. Kennedy, 2008 .

P2Y receptors in GtoPdb v.2023.1

G. Burnstock, K. Jacobson, C. Müller, 2023, IUPHAR/BPS Guide to Pharmacology CITE.

Evidence that ATP acts at two sites to evoke contraction in the rat isolated tail artery

K. Burke, C. Kennedy, P. Sneddon, 1998, British journal of pharmacology.

Vascular P2 — Receptors and their Possible Role in Hypertension

C. Kennedy, 1998 .

ATP as a cotransmitter in perivascular sympathetic nerves.

C. Kennedy, 1996, Journal of autonomic pharmacology.

The importance of drug discovery for treatment of cardiovascular diseases.

C. Kennedy, 2013, Future medicinal chemistry.

Characterization of a P2X‐purinoceptor in cultured neurones of the rat dorsal root ganglia

E. Rowan, C. Kennedy, E G Rowan, 1996, British journal of pharmacology.

Chapter 2 Modulation of purinergic neurotransmission

C. Kennedy, P. Sneddon, D. Westfall, 1999 .

Cellular mechanisms underlying the excitatory actions of ATP in vascular smooth muscle

C. Kennedy, 1993 .

P2Y1 and P2Y12 receptor heterodimerisation : from recombinant systems to native detection

C. Kennedy, R. Tate, M. Cunningham, 2018 .

P2Y receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

G. Burnstock, K. Jacobson, C. Müller, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Two-pore potassium ion channels are inhibited by both Gq/11- and Gi-coupled P2Y receptors

T. Bushell, C. Kennedy, Miralkumar Parmar, 2010, Molecular and Cellular Neuroscience.

An examination of the putative o-receptor in the mouse isolated vas deferens

G. Henderson, C. Kennedy, 2006 .

Potent vasoconstrictor actions of α,β-methylene ATP, a stable analogue of ATP, on the rat vasculature, in vivo

G. Burnstock, C. Kennedy, D. Delbro, 1985 .

Potent vasoconstrictor actions of alpha, beta-methylene ATP, a stable analogue of ATP, on the rat vasculature, in vivo.

G. Burnstock, C. Kennedy, D. Delbro, 1985, Acta physiologica Scandinavica.

P2X3 receptors and sensory transduction

C. Kennedy, 2008 .

Tumour necrosis factor stimulates stress-activated protein kinases and the inhibition of DNA synthesis in cultures of bovine aortic endothelial cells.

R. Plevin, G. Gould, C. Kennedy, 1998, Cellular signalling.

Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.

G. Henderson, C. Kennedy, 1991, Molecular pharmacology.

Characterization of the neurons of the mouse hypogastric ganglion: morphology and electrophysiology.

G. Henderson, C. Kennedy, H. Rogers, 1990, Journal of the autonomic nervous system.

International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.

B. Khakh, R. North, G. Burnstock, 2001, Pharmacological reviews.

Modulation of purinergic neurotransmission.

C. Kennedy, P. Sneddon, D. Westfall, 1999, Progress in brain research.

Release of soluble nucleotidases: a novel mechanism for neurotransmitter inactivation?

C. Kennedy, P. Sneddon, L. Todorov, 1997, Trends in pharmacological sciences.

Pulmonary, Gastrointestinal and Urogenital Pharmacology Characterisation of P2X receptors expressed in rat pulmonary arteries

C. Kennedy, A. Paul, A. Tengah, 2010 .